|
There is on-going development of generic EU CTD Dossier of Irbesartan-hydrochlorothiazide, filmcoated tablets, 150+12.5/300+12.5 mg.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|
|
Read more...
|
|
|
There is on-going development of generic EU CTD Dossier of Repaglinide, tablets, 0.5/1/2 mg.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|
|
Read more...
|
|
|
There is on-going development of generic EU CTD Dossier of Ropinirole HCl, filmcoated tablets, 0.25/0.5/1/2 mg.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|
|
Read more...
|
|
|
There is on-going development of generic EU CTD Dossier of Olanzapine, mouth dissolving tablets, 5/10/15/20 mg.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|
|
Read more...
|
|
|
There is on-going development of generic EU CTD Dossier of Oxcarbazepine, filmcoated tablets, 150/300/600 mg.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 28 - 36 of 312 |
Pharma Licensing 
